JK

Jigneshkumar Kanubhai Thakkar

Active Director Director DIN 10994612
DIN 10994612 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Jigneshkumar Kanubhai Thakkar

Data last updated:

Jigneshkumar Kanubhai Thakkar is a Director at Jkdh Pharma Private Limited (since 2025). The company operates in Pharma.

DIN 10994612
Primary Designation Director
Industry Pharma
First Appointment 10 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jkdh Pharma Private Limited U46497GJ2025PTC160129
Director10 Mar 20252025Active

Board colleagues of Jigneshkumar Kanubhai Thakkar

Directorship timeline

Open interactive timeline →
Jkdh Pharma Private Limited
Premium access

Shareholding and investment profile for Jigneshkumar Kanubhai Thakkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jigneshkumar Kanubhai Thakkar

Jigneshkumar Kanubhai Thakkar currently holds 1 directorship: Jkdh Pharma Private Limited (Director, since 10 Mar 2025).

Jigneshkumar Kanubhai Thakkar was first appointed on 10 Mar 2025 as Director at Jkdh Pharma Private Limited.

The current boards of Jigneshkumar Kanubhai Thakkar's companies include Dhaval Kanubhai Thakkar (Jkdh Pharma Private Limited), Hiren Thakkar (Jkdh Pharma Private Limited), Kiritkumar Thakkar (Jkdh Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available